 | Up a level |
Jörger Messerli, Marianne; Brühlmann, Esther; Bessire, Anice; Wagner, Anna Margaretha; Mueller, Martin; Surbek, Daniel; Schoeberlein, Andreina (2014). Preeclampsia enhances neuroglial marker expression in umbilical cord Wharton's jelly-derived mesenchymal stem cells. The journal of maternal-fetal & neonatal medicine, 28(4), pp. 464-469. 10.3109/14767058.2014.921671
Messerli, Marianne; Wagner, Anna; Sager, Ruth; Mueller, Martin; Baumann, Marc; Surbek, Daniel V; Schoeberlein, Andreina (2013). Stem Cells From Umbilical Cord Wharton's Jelly From Preterm Birth Have Neuroglial Differentiation Potential. Reproductive sciences, 20(12), pp. 1455-1464. Thousand Oaks, Calif.: Sage
Wagner, Anna Margaretha; Krenger, Werner; Holzgreve, Wolfgang; Bürkli, Peter; Surbek, Daniel V. (2013). Use of human embryonic stem cells and umbilical cord blood stem cells for research and therapy: a prospective survey among health care professionals and patients in Switzerland. Transfusion, 53(11), pp. 2681-2689. Malden, Mass.: Wiley-Blackwell
Wagner, Anna-Margaretha; Krenger, Werner; Suter, Eva; Ben Hassem, Dorra; Surbek, Daniel V. (2013). High acceptance rate of hybrid allogeneic-autologous umbilical cord blood banking among actual and potential Swiss donors. Transfusion, 53(7), pp. 1510-1519. Malden, Mass.: Wiley-Blackwell 10.1111/j.1537-2995.2012.03921.x
Messerli, M; Schoeberlein, A; Wagner, A; Sager, R; Surbek, D (2012). Umbilical cord Wharton's jelly-derived mesenchymal stem cells have neural differentiation potential. In: AM J Obstet Gynecol (206:S37-8). AM J Obstet Gynecol
Messerli, M; Schoeberlein, A; Wagner, A; Sager, R; Surbek, D (2011). Mesenchymale Stammzellen aus Nabelschnurgewebe haben neurogenes Differenzierungspotential. In: Jahreskongress SGGG, Lugano 2011. Jahreskongress SGGG, Lugano 2011
Messerli, M; Schoeberlein, A; Wagner, A; Sager, R; Surbek, D (2011). Neural differentiation potential of human umbilical cord Whartons jelly-derived cells. In: AM J Obstet Gynecol (S162). AM J Obstet Gynecol
Wagner, AM; Stettler, S; Beutler, E; Studer, H; Baerlocher, GM; Surbek, DV (2011). Welche Methoden und Nabelschnurblut-Proben eignen sich zur Bestimmung der kernhaltigen Zellen im Nabelschnurblut-Transplantate? In: Jahreskongress SGGG, Lugano 2011. Jahreskongress SGGG, Lugano 2011
Schreiber-Facklam, Heide; Wagner, Anna M; Staehler, Kirsten; Surbek, Daniel; Kappeler, Andreas; Zimmermann, Arthur; Vajtai, Istvan (2009). "Exterritorial" lymphocytic hypophysitis within an ovarian teratoma during pregnancy: a possible sentinel lesion? Pathology, research and practice, 205(1), pp. 51-6. München: Elsevier 10.1016/j.prp.2008.08.005
Wagner, Anna M; Schoeberlein, Andreina; Surbek, Daniel (2009). Fetal gene therapy: opportunities and risks. Advanced drug delivery reviews, 61(10), pp. 813-21. Amsterdam: Elsevier 10.1016/j.addr.2009.04.011
Surbek, Daniel; Schoeberlein, Andreina; Wagner, Anna (2008). Perinatal stem-cell and gene therapy for hemoglobinopathies. Seminars in fetal and neonatal medicine, 13(4), pp. 282-90. Amsterdam: Elsevier 10.1016/j.siny.2008.03.002
Troeger, C; Meyer-Monnard, S; Tichelli, A; Bart, T; Surbek, D; Wagner, A; Holzgreve, W (2008). Nabelschnurblutspende: Relevante Fakten. Gynäkologisch-geburtshilfliche Rundschau(48), pp. 241-244. Basel: Karger
Wagner, AM; Portmann-Lanz, CB; Surbek, D (2008). Isolation and Characterisation of Mesenchymal Stem Cells from Umbilical Cord. In: DKF Forschungstag.
Wagner, AM; Nuoffer, JM; Christ, E; Ziegler, R; McDougall, J; Kersten, DJ; Surbek, D (2008). Maternale Phenylketonurie in der Schwangerschaft: Grenzen der diätetischen Therapie zur Verbesserung des fetalen Outcome. In: Jahreskongress 2008 der Schweizerischen Gesellschaft für Chirurgie.
